Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
Clinical trial NCT02535221 · RECRUITING
Trial details
- NCT number
- NCT02535221
- Sponsor
- Peking University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-29
- Primary completion
- 2026-06-30
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.